5-BROMO-3-(1-METHYL-1,2,3,6-TETRAHYDROPYRIDIN-4-YL)-1H-PYRROLO[2,3-B]PYRIDINE, 95.0%, 250mg

3-Chloro-2-(chloromethyl)-2-methylpropanoic acid, 98%, 1g

(4R,12aS)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid, 1g

4-carboethoxy-4'-piperidinomethyl benzophenone, 97.0%, 1g

(R)-Methyl 3-aminobutanoate, 95.0%, 1g

9-Phenyl-9H-xanthen-9-ol, 97.0%, 250mg

Methyl 6-bromo-1H-pyrrolo[2,3-b]pyridine-3-carboxylate, 95.0%, 25mg

Spectra/Por® 4, Dialysemembranen, MWCO 12000 - 14000, Breite 32 mm, 1 Stück

3-Amino-5-methylthio-1H-1,2,4-triazole>97.0%(GC)(T)25g

2-methyl-5,6-dihydro-1,4-oxathiine-3-carboxylic acid 4,4-dioxide, 95.0%, 250mg

5-Fluoro-2-(trifluoromethoxy)benzoic acid, 98.0%, 5g

5-(4-Methoxyphenyl)pyrimidin-2-ylamine, 95.0%, 250mg

N1-(6-(4,5-dimethyl-1H-imidazol-1-yl)pyrimidin-4-yl)ethane-1,2-diamine, 95.0%, 500mg